gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Dec 2016.

Progesterone immunomodulatory binding factor 1

PIBF, progesterone-induced blocking factor
Top mentioned proteins: TH2, V1a, IL-10, CAN, HAD
Papers on PIBF
Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF).
Dougherty et al., Philadelphia, United States. In J Assist Reprod Genet, Jan 2016
PURPOSE: To determine if exposure to progesterone alone is sufficient to increase the production of the immunomodulatory protein known as the progesterone induced blocking factor (PIBF).
[Expression of progesterone-induced blocking factor in severe preeclampsia and its association with immune tolerance imbalance].
Yang et al., Guangzhou, China. In Nan Fang Yi Ke Da Xue Xue Bao, Jun 2015
OBJECTIVE: To explore progesterone-induced blocking factor (PIBF) expression in the placenta and blood of patients with severe preeclampsia and its relationship with immune tolerance imbalance.
Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth.
Fatušić et al., Tuzla, Bosnia and Herzegovina. In J Reprod Immunol, Jun 2015
The objective of this study was to analyze the maternal serum concentration of progesterone-induced blocking factor (PIBF) with regard to the prediction and the interval between sampling and the onset of preterm birth.
Serum levels of the progesterone induced blocking factor do not precipitously rise in women with gynecologic cancer in contrast to women exposed to progesterone.
Duroseau et al., In Clin Exp Obstet Gynecol, 2014
MATERIALS AND METHODS: A newly developed enzyme linked immunoabsorbent assay (ELISA) assay was used to measure PIBF in the sera of six women with various gynecologic cancers and compare them to five controls (three with benign tumors and two having gynecologic procedures for non-tumors.
How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage?
Tan et al., Singapore, Singapore. In Gynecol Endocrinol, 2014
This study seeks to establish progesterone and progesterone-induced blocking factor (PIBF) levels as predictors of subsequent completed miscarriage among women presenting with threatened miscarriage between 6 and 10 weeks of gestation.
Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.
Camacho-Arroyo et al., Mexico. In J Steroid Biochem Mol Biol, 2014
Recently, it has been found that P4 induces the growth of several tumors through the up-regulation of progesterone-induced blocking factor (PIBF), a protein that has been related to the immunologic and proliferative actions of P4.
Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF).
Kyurkchiev et al., Sofia, Bulgaria. In Cell Mol Neurobiol, 2014
Progesterone-induced blocking factor (PIBF) is an immunomodulatory protein with known role in the regulation of the immune response in the reproductive system.
Mifepristone causing complete remission of rapidly advancing leukemia with measurement of progesterone-induced blocking factor.
Sarumi et al., York, United States. In Anticancer Res, 2014
The aim of the present study was to determine if rapidly advancing chronic lymphocytic leukemia responds to mifepristone therapy, and if so, is this effect related to increased expression of the progesterone-induced blocking factor?
Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV.
Sarumi et al., York, United States. In Anticancer Res, 2014
The theory of its mechanism is that it prevents the secretion of a progesterone-induced immunomodulatory protein in the tumor microenvironment, or in the tumor cell itself, called the progesterone-induced blocking factor, which inhibits natural killer cells from attacking the cancer cell.
Progesterone induced blocking factor isoforms in normal and failed murine pregnancies.
Szekeres-Bartho et al., Pécs, Hungary. In Am J Reprod Immunol, 2014
PROBLEM: Progesterone induced blocking factor (PIBF) is required for successful pregnancy.
Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
Mandžić et al., Tuzla, Bosnia and Herzegovina. In J Reprod Immunol, 2011
increased serum levels after dydrogesterone supplementation in women with threatened preterm delivery; positive correlation with the length of gestation
Changes of progesterone-induced blocking factor in patients after kidney transplantation.
Ferencz et al., Pécs, Hungary. In Transplant Proc, 2011
Suggest that urinary PIBF levels may predict graft rejection in transplant recipients.
Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.
Szekeres-Bartho et al., Pécs, Hungary. In J Reprod Immunol, 2011
PIBF affects the expression of leptin and its receptor, and PIBF expression is inversely related to trophoblast invasiveness.
[PIBF - Progesterone-Induced Blocking Factor].
Markert et al., Jena, Germany. In Z Geburtshilfe Neonatol, 2011
One of these factors is progesterone-induced blocking factor (PIBF).
The pericentriolar satellite protein CEP90 is crucial for integrity of the mitotic spindle pole.
Rhee et al., Seoul, South Korea. In J Cell Sci, 2011
CEP90 was characterized as a component of pericentriolar satellites.
Effect of progesterone on human mesenchymal stem cells.
Kyurkchiev et al., Sofia, Bulgaria. In Vitam Horm, 2010
The endometrial MSCs are stimulated by progesterone to increase the expression and secretion of immunomodulatory proteins such as HLA-G and PIBF.
PIBF: the double edged sword. Pregnancy and tumor.
Polgar et al., Pécs, Hungary. In Am J Reprod Immunol, 2010
role of PIBF in both normal pregnancy and tumor biology [REVIEW]
Progesterone in pregnancy; receptor-ligand interaction and signaling pathways.
Palkovics et al., Pécs, Hungary. In J Reprod Immunol, 2009
A protein called progesterone-induced blocking factor (PIBF), by inducing a Th2-dominant cytokine production mediates the immunological effects of progesterone.
Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage.
Szekeres-Bartho, Pécs, Hungary. In Immunotherapy, 2009
Several immunological effects of progesterone are mediated by progesterone-induced blocking factor--the product of a progesterone-induced gene in lymphocytes.
share on facebooktweetadd +1mail to friends